Skip to Main Content

Author Details

Surena F Matin
The University of Texas MD Anderson Cancer Center
1997
331
57
PMIDPaper TitleJournal TitlePublished Year
37442673The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features.Eur Urol Oncol2024
37802194Ileal Interposition for Ureteral Reconstruction Following Treatment for Abdominopelvic Malignancy: Complications and Outcomes From a Comprehensive Cancer Center.Urology2024
37640582Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)].Eur Urol Focus2024
36657029Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.J Urol2023
38020520Effectiveness of Thermal Ablation for Renal Cell Carcinoma after Prior Partial Nephrectomy.Eur Urol Open Sci2023
37833193Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.Eur Urol Oncol2023
37690543Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients.Urology2023
37059620Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.Eur Urol Focus2023
37149462Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.Eur Urol2023
37246135The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.Urol Oncol2023
37268448Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610.Eur Urol Oncol2023
37164948Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.Nat Commun2023
37096584Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline.J Urol2023
37263827Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.Eur Urol Focus2023
36642620Optimizing Lymph Node Dissection at the Time of Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma.Eur Urol Focus2023
36773986EDITORIAL COMMENT.Urology2023
36424224Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.Urol Oncol2023
36765867Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience.Cancers (Basel)2023
36793750Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies.Eur Urol Open Sci2023
36861106Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals.Eur Urol Open Sci2023
34228889Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.BJU Int2022
35961847Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma.Urol Oncol2022
36082549Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study.J Urol2022
33773965Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.Eur Urol Focus2022
34985341Reply by Authors.J Urol2022
35279419Predictors of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus.Clin Genitourin Cancer2022
35039231Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.Clin Genitourin Cancer2022
35236102Editorial Comment.J Urol2022
34962705Lymphangioembolization for iatrogenic chylous ascites after retroperitoneal urological surgery.BJU Int2022
34547921Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy.J Urol2022
32981193Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.BJU Int2021
35475152Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma.BJUI Compass2021
35474874Long-term renal functional outcomes following ureteroureterostomy performed during multi-organ resection for non-urothelial cancers.BJUI Compass2021
33909469Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies.AJR Am J Roentgenol2021
33881933Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma.J Urol2021
33908802The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis.J Urol2021
33676955Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase.Urology2021
33484074Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.BJU Int2021
34737281Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma.Nat Commun2021
34758553EDITORIAL COMMENT.Urology2021
34551888Tumor diameter response in patients with metastatic clear cell renal cell carcinoma is associated with overall survival.Urol Oncol2021
34159106Role of lymph node dissection at the time of open or minimally invasive nephroureterectomy.Transl Androl Urol2021
34105990Editorial Comment.J Urol2021
34301458Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma.Urol Oncol2021
34121427Reply by Authors.J Urol2021
34228501The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-analysis. Reply.J Urol2021
34023164Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.Eur Urol2021
34330655Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinoma.Urol Oncol2021
31685445Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy.Eur Urol Focus2021
33187886Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors.Urol Oncol2021
  • 1 - 50 of 331

Recommended Authors

Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Riccardo Campi
Careggi University Hospital
Career Start Year 2014
Number of shared co-authors 10
Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 3
David C Johnson
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 2
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 4
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 2
Shinji Ohtake
Institute of Urologic Oncology, University of California los angeles
Career Start Year 2010
Number of shared co-authors 2
Aydin Pooli
David Geffen School of Medicine, University of California los angeles
Career Start Year 2008
Number of shared co-authors 2
Joseph Brito
Yale School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Paul L Crispen
University of Florida
Career Start Year 2005
Number of shared co-authors 6
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 1
Chang Wook Jeong
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Timothy D McClure
Weill Cornell Medical College/New York Presbyterian
Career Start Year 2002
Number of shared co-authors 6
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Nimish Shah
Cambridge University Hospitals NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 1
Brian A Costello
The Mayo Clinic
Career Start Year 2001
Number of shared co-authors 10
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Hyun Moo Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Cheol Kwak
Seoul National University Hospital, Seoul National University College of Medicine
Career Start Year 2000
Number of shared co-authors 1
Seong Il Seo
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1999
Number of shared co-authors 0
Hak J Lee
university of california san diego School of Medicine
Career Start Year 1998
Number of shared co-authors 2
Omer Acar
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 0
Vincent G Bird
University of Florida College of Medicine
Career Start Year 1995
Number of shared co-authors 0
David Nicol
The Royal Marsden Hospital
Career Start Year 1993
Number of shared co-authors 2
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 1
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 4
Peter G Schulam
Yale University
Career Start Year 1990
Number of shared co-authors 2
Damien Bolton
University of Melbourne
Career Start Year 1988
Number of shared co-authors 1
Yong Hyun Park
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Career Start Year 1987
Number of shared co-authors 1
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 9

Collaborators

Colin P Dinney
The University of Texas MD Anderson Cancer Center
Co-authored papers 30
Philippe E Spiess
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 17
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 13
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Co-authored papers 9
Phillip M Pierorazio
Co-authored papers 8
Qingyi Wei
South China University of Technology
Co-authored papers 8
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Douglas S Scherr
New York-Presbyterian Hospital
Co-authored papers 6
Karim Chamie
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Lance C Pagliaro
Mayo Clinic
Co-authored papers 4
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers 4
Yu Shen
Co-authored papers 4
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 4
Ian E McCutcheon
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 4
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 3
Yuan Qi
Co-authored papers 3
David J McConkey
Johns Hopkins School of Medicine
Co-authored papers 3
Arnulf Stenzl
Eberhard Karls University of Tubingen
Co-authored papers 2
Ithaar H Derweesh
university of california san diego School of Medicine
Co-authored papers 2
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers 2
Michael A Carducci
Johns Hopkins School of Medicine
Co-authored papers 2
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Robert L Satcher
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Beom-Jun Kim
Asan Medical Center, University of Ulsan College of Medicine
Co-authored papers 2
Alda L Tam
MD Anderson Cancer Center
Co-authored papers 2
Andrew K Lee
Texas Center for Proton Therapy
Co-authored papers 2
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Co-authored papers 2
Tristan Juvet
Lions Gate Hospital
Co-authored papers 2
John L Gore
University of Washington School of Medicine
Co-authored papers 2
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 1
Release 1.2